Calamos Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.44M | Hold |
|
|||||
|
2025
Q1 | $7.78M | Sell |
|
|||||
|
2024
Q4 | $16.1M | Buy |
|
|||||
|
2024
Q3 | $12.8M | Sell |
|
|||||
|
2024
Q2 | $13.1M | Sell |
|
|||||
|
2024
Q1 | $12.4M | Sell |
|
|||||
|
2023
Q4 | $11.6M | Sell |
|
|||||
|
2023
Q3 | $11M | Hold |
|
|||||
|
2023
Q2 | $9.62M | Hold |
|
|||||
|
2023
Q1 | $11M | Sell |
|
|||||
|
2022
Q4 | $10.9M | Sell |
|
|||||
|
2022
Q3 | $12.2M | Sell |
|
|||||
|
2022
Q2 | $10.5M | Buy |
|
|||||
|
2022
Q1 | $12.1M | Buy |
|
|||||
|
2021
Q4 | $9.44M | Buy |
|
|||||
|
2021
Q3 | $8.69M | Buy |
|
|||||
|
2021
Q2 | $7.32M | Buy |
|
|||||
|
2021
Q1 | $4.79M | Buy |
|
|||||
|
2020
Q4 | $4.74M | Sell |
|
|||||
|
2020
Q3 | $5.73M | Sell |
|
|||||
|
2020
Q2 | $6.95M | Sell |
|
|||||
|
2020
Q1 | $5.79M | Sell |
|
|||||
|
2019
Q4 | $4.82M | Sell |
|
|||||
|
2019
Q3 | $3.62M | Buy |
|
|||||
|
2019
Q2 | $3.73M | Buy |
|
|||||
|
2019
Q1 | $4.79M | Buy |
|
|||||
|
2018
Q4 | $4.18M | Buy |
|
|||||
|
2018
Q3 | $3.85M | Sell |
|
|||||
|
2018
Q2 | $5.05M | Sell |
|
|||||
|
2018
Q1 | $5.92M | Sell |
|
|||||
|
2017
Q4 | $45.2M | Buy |
|
|||||
|
2017
Q3 | $31M | Buy |
|
|||||
|
2017
Q2 | $5.74M | Buy |
|
|||||
|
2017
Q1 | $3.03M | Buy |
|
|||||
|
2016
Q4 | $1.47M | Sell |
|
|||||
|
2016
Q3 | $1.64M | Buy |
|
|||||
|
2016
Q2 | $1.42M | Buy |
|
|||||
|
2016
Q1 | $1.46M | Buy |
|
|||||
|
2015
Q4 | $2.07M | Hold |
|
|||||
|
2015
Q3 | $1.77M | Buy |
|
|||||
|
2015
Q2 | $1.94M | Sell |
|
|||||
|
2015
Q1 | $12.2M | Sell |
|
|||||
|
2014
Q4 | $79.6M | Sell |
|
|||||
|
2014
Q3 | $110M | Sell |
|
|||||
|
2014
Q2 | $91.6M | Sell |
|
|||||
|
2014
Q1 | $112M | Buy |
|
|||||
|
2013
Q4 | $92M | Sell |
|
|||||
|
2013
Q3 | $105M | Buy |
|
|||||
|
2013
Q2 | $72.5M | Buy |
|